MX2013010354A - Derivados de isoxazolidina. - Google Patents

Derivados de isoxazolidina.

Info

Publication number
MX2013010354A
MX2013010354A MX2013010354A MX2013010354A MX2013010354A MX 2013010354 A MX2013010354 A MX 2013010354A MX 2013010354 A MX2013010354 A MX 2013010354A MX 2013010354 A MX2013010354 A MX 2013010354A MX 2013010354 A MX2013010354 A MX 2013010354A
Authority
MX
Mexico
Prior art keywords
isoxazolidine
derivatives
relates
isoxazolidine derivatives
compounds
Prior art date
Application number
MX2013010354A
Other languages
English (en)
Other versions
MX345400B (es
Inventor
Eleonora Ghidini
Andrea Rizzi
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44351355&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2013010354(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of MX2013010354A publication Critical patent/MX2013010354A/es
Publication of MX345400B publication Critical patent/MX345400B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0057—Nitrogen and oxygen
    • C07J71/0068—Nitrogen and oxygen at position 16(17)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se relaciona con novedosos compuestos antiinflamatorios y antialérgicos de la serie de los glucocorticosteroides, métodos para preparar los compuestos, composiciones farmacéuticas que comprenden a los mismos y combinaciones y usos terapéuticos de los mismos. Más particularmente, la invención se relaciona con glucocorticosteroides que son derivados de isoxazolidina.
MX2013010354A 2011-03-15 2012-03-14 Derivados de isoxazolidina. MX345400B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11158230 2011-03-15
PCT/EP2012/054439 WO2012123482A2 (en) 2011-03-15 2012-03-14 Isoxazolidine derivatives

Publications (2)

Publication Number Publication Date
MX2013010354A true MX2013010354A (es) 2013-12-06
MX345400B MX345400B (es) 2017-01-30

Family

ID=44351355

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013010354A MX345400B (es) 2011-03-15 2012-03-14 Derivados de isoxazolidina.

Country Status (22)

Country Link
US (3) US20120234316A1 (es)
EP (2) EP2686332A2 (es)
JP (1) JP6053700B2 (es)
KR (1) KR101956937B1 (es)
CN (1) CN103391945B (es)
AR (1) AR085817A1 (es)
AU (1) AU2012228334B2 (es)
BR (1) BR112013023539B1 (es)
CA (1) CA2850081C (es)
CL (1) CL2013002629A1 (es)
EA (1) EA028904B1 (es)
GE (1) GEP201606566B (es)
IL (1) IL228382A (es)
MX (1) MX345400B (es)
MY (1) MY194140A (es)
PE (1) PE20140890A1 (es)
SG (1) SG193262A1 (es)
TN (1) TN2013000313A1 (es)
TW (1) TWI658047B (es)
UA (1) UA113508C2 (es)
WO (1) WO2012123482A2 (es)
ZA (2) ZA201306881B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2843782A1 (en) 2011-08-01 2013-02-07 Chiesi Farmaceutici S.P.A. Anti-inflammatory steroids condensed in position 16,17 with pyrrolidine ring
US9155747B2 (en) 2012-09-13 2015-10-13 Chiesi Farmaceutici S.P.A. Isoxazolidine derivatives
EP2902382A1 (en) * 2014-01-30 2015-08-05 Fundació Institut de Recerca Biomèdica IRB (Barcelona) Primary hydroxylamines and uses thereof
CA3158795A1 (en) * 2014-03-31 2015-10-08 The Scripps Research Institute Pharmacophore for trail induction
EA038527B1 (ru) 2014-09-03 2021-09-10 Ризен Фармасьютикалз Са Способ лечения респираторного заболевания или состояния, композиции и наборы, содержащие двойной ингибитор киназ pi3k дельта-гамма и кортикостероид
CN104262440B (zh) * 2014-09-10 2016-08-17 江西赣亮医药原料有限公司 一种16ɑ-羟基泼尼松龙的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL31997A (en) * 1968-05-03 1974-03-14 Lepetit Spa Process for the preparation of pregnano(17alpha,16alpha-d)oxazolines and 16alpha,21-dihydroxy-17alpha-aminopregnanes
US4018774A (en) 1976-02-13 1977-04-19 E. R. Squibb & Sons, Inc. Steroidal [16α,17-d]isoxazolidines
PT69410A (fr) * 1978-04-05 1979-04-01 Syntex Inc Process pour preparation de 4-6-dihalo steroids
WO2005028495A1 (en) * 2003-09-24 2005-03-31 Glaxo Group Limited Anti-inflammatory glucocorticoids
GB0415747D0 (en) * 2004-07-14 2004-08-18 Novartis Ag Organic compounds
WO2006074187A2 (en) 2005-01-03 2006-07-13 Myriad Genetics, Inc. Method of treating brain cancer
WO2009069032A2 (en) * 2007-11-30 2009-06-04 Pfizer Limited Novel glucocorticoid receptor agonists
CA2716476A1 (en) * 2008-02-27 2009-09-03 Astrazeneca Ab 16 alpha, 17 alpha-acetal glucocorticosteroidal derivatives and their use
CN101926805A (zh) * 2009-06-24 2010-12-29 天津金耀集团有限公司 一种含有16,17异恶唑烷类甾体化合物的药物组合物
ME01331B (me) * 2009-09-11 2013-12-20 Chiesi Farm Spa Derivati izoksazolidina
TW201139369A (en) 2010-02-05 2011-11-16 Chiesi Farma Spa Pyrrolidine derivatives
BR112013022890A2 (pt) 2011-03-15 2016-09-13 Chiesi Farma Spa composto, composição farmacêutica, combinação e uso de um composto
CA2843782A1 (en) 2011-08-01 2013-02-07 Chiesi Farmaceutici S.P.A. Anti-inflammatory steroids condensed in position 16,17 with pyrrolidine ring
US9155747B2 (en) 2012-09-13 2015-10-13 Chiesi Farmaceutici S.P.A. Isoxazolidine derivatives

Also Published As

Publication number Publication date
EP2716648A1 (en) 2014-04-09
JP6053700B2 (ja) 2016-12-27
CN103391945A (zh) 2013-11-13
ZA201405681B (en) 2015-12-23
EP2716648B1 (en) 2017-06-14
TN2013000313A1 (en) 2015-01-20
AU2012228334B2 (en) 2017-03-23
CN103391945B (zh) 2016-11-09
ZA201306881B (en) 2014-11-26
US20180066010A1 (en) 2018-03-08
TWI658047B (zh) 2019-05-01
EA028904B1 (ru) 2018-01-31
UA113508C2 (xx) 2017-02-10
BR112013023539A2 (pt) 2017-01-24
WO2012123482A2 (en) 2012-09-20
CA2850081A1 (en) 2012-09-20
KR20140006016A (ko) 2014-01-15
MX345400B (es) 2017-01-30
US9845337B2 (en) 2017-12-19
GEP201606566B (en) 2016-11-10
TW201247697A (en) 2012-12-01
US10280193B2 (en) 2019-05-07
US20120234316A1 (en) 2012-09-20
EA201391173A1 (ru) 2014-01-30
AU2012228334A1 (en) 2013-10-03
SG193262A1 (en) 2013-10-30
IL228382A (en) 2017-08-31
KR101956937B1 (ko) 2019-03-11
PE20140890A1 (es) 2014-08-05
IL228382A0 (en) 2013-12-31
CA2850081C (en) 2020-01-07
BR112013023539B1 (pt) 2022-03-03
AR085817A1 (es) 2013-10-30
EP2686332A2 (en) 2014-01-22
WO2012123482A3 (en) 2013-02-07
CL2013002629A1 (es) 2014-01-10
JP2014508181A (ja) 2014-04-03
US20150057257A1 (en) 2015-02-26
MY194140A (en) 2022-11-14
NZ615423A (en) 2015-08-28

Similar Documents

Publication Publication Date Title
MY164842A (en) Isoxazolidine derivatives
PH12016500094A1 (en) Autotaxin inhibitors
UA109868C2 (ru) Соединения n-алкилтриазола как антагонисты лизофосфатидной кислоты (lpar)
TN2015000278A1 (en) Autotaxin inhibitors
MX368263B (es) Compuestos novedosos y composiciones farmaceuticas de los mismos para el tratamiento de fibrosis quistica.
PH12014501514A1 (en) New azetidine derivatives, pharmaceutical compositions and uses thereof
IN2014DN09352A (es)
PH12015500376A1 (en) Novel bicyclic pyridinones
TN2013000313A1 (en) Isoxazolidine derivatives
IN2014DN09347A (es)
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
WO2011095535A3 (en) Pregnane compounds condensed in position 16,17 with a pyrolidine ring with glucocorticoid activity
AU2014324961A8 (en) Highly potent glucocorticoids
PH12015500534B1 (en) Isoxazolidine derivatives
MX2015001657A (es) Compuestos de cianopirazol substituidos con receptores de acido lisofosfatidico (lpar).
WO2012123493A3 (en) Isoxazolidine derivatives
MX2013009386A (es) Nuevos compuestos de azaespirodecanona.
WO2014122671A3 (en) Solid oral compositions of saxagliptin
IN2015DN02660A (es)

Legal Events

Date Code Title Description
FG Grant or registration